Tu Teng, Yuan Ye, Liu Xiaoxue, Liang Xin, Yang Xiaofan, Yang Yue
School of Basic Medicine, Mudanjiang Medical College, Mudanjiang, Heilongjiang, China.
Beidahuang Industry Group General Hospital, Harbin, China.
Front Oncol. 2023 Sep 11;13:1248825. doi: 10.3389/fonc.2023.1248825. eCollection 2023.
The Schlafen5(SLFN5)gene belongs to the third group of the Schlafen protein family. As a tumor suppressor gene, SLFN5 plays a pivotal role in inhibiting tumor growth, orchestrating cell cycle regulation, and modulating the extent of cancer cell infiltration and metastasis in various malignancies. However, the high expression of SLFN 5 in some tumors was positively correlated with lymph node metastasis, tumor stage, and tumor grade. This article endeavors to elucidate the reciprocal relationship between the SLFN5 gene and malignant tumors, thereby enhancing our comprehension of the intricate mechanisms underlying the SLFN5 gene and its implications for the progression, invasive potential, and metastatic behavior of malignant tumors. At the same time, this paper summarizes the basis of SLFN 5 as a new biomarker of tumor diagnosis and prognosis, and provides new ideas for the target treatment of tumor.
施拉芬5(SLFN5)基因属于施拉芬蛋白家族的第三组。作为一种肿瘤抑制基因,SLFN5在抑制肿瘤生长、协调细胞周期调控以及调节各种恶性肿瘤中癌细胞浸润和转移程度方面发挥着关键作用。然而,SLFN 5在某些肿瘤中的高表达与淋巴结转移、肿瘤分期和肿瘤分级呈正相关。本文旨在阐明SLFN5基因与恶性肿瘤之间的相互关系,从而加深我们对SLFN5基因复杂机制及其对恶性肿瘤进展、侵袭潜能和转移行为影响的理解。同时,本文总结了SLFN 5作为肿瘤诊断和预后新生物标志物的依据,并为肿瘤的靶向治疗提供新思路。